French Validation of the Recovery Assessment Scale (RAS-FR) (VAL-RAS-FR)
Cross-Cultural Adaptation, French Validation, and Development of Derived Versions of the Recovery Assessment Scale (RAS) for the Assessment of Subjective Recovery in Mental Health
調査の概要
詳細な説明
Recovery in mental health extends beyond symptom reduction and includes hope, self-confidence, autonomy, meaning, and continuity of self. As described by Anthony (1993) and further developed through the CHIME framework, recovery is a deeply personal process involving connectedness, hope, identity, meaning, and empowerment. Although French translations of the Recovery Assessment Scale (RAS) have been used previously, no comprehensive psychometric validation of a French version is currently available for routine use in French-speaking psychiatric settings.
VAL-RAS-FR is a monocentric, prospective, observational study designed to cross-culturally adapt, validate, and develop derived versions of the 41-item Recovery Assessment Scale (RAS) for use in French-speaking mental health settings. The study will enroll 260 adult psychiatric patients receiving care at EPSM Metz-Jury, including patients from inpatient units, day hospital settings, community mental health centers (CMP), and EPSIAD follow-up services. Participants will complete self-report questionnaires including the French version of the RAS (RAS-FR), the WHOQOL-BREF, and complementary questionnaires exploring factors associated with subjective recovery. A subgroup of 50 participants will complete the RAS-FR again after one month to assess test-retest reliability.
The study has three complementary objectives. First, it aims to evaluate the psychometric properties of the French version of the RAS, including validity, internal consistency, dimensional structure, and test-retest reliability. Second, it will explore an existential dimension of recovery through the development of the RAS-FR-EX (Existential Extension), an exploratory extension designed to assess aspects such as continuity of self, reconstruction of meaning, and the experience of existing after psychological crisis. Third, it will support the exploratory development of a shorter version of the scale, the RAS-FR-SF (Short Form), intended to facilitate future clinical use while preserving the core dimensions of subjective recovery.
The study does not involve any modification of usual care, invasive procedures, or additional medical examinations. By combining psychometric validation with exploratory clinical development, VAL-RAS-FR aims to provide a validated French-language measure of subjective recovery, improve the assessment of recovery-oriented outcomes in psychiatric care, and contribute to the development of clinically useful tools for French-speaking mental health services.
研究の種類
入学 (推定)
連絡先と場所
研究連絡先
- 名前:Audrey WILLIG, Psychologist
- 電話番号:+33695082545
- メール:audrey.willig@gmail.com
研究連絡先のバックアップ
- 名前:Claire GARIOT, PhD
- 電話番号:+33387561234
- メール:claire.gariot@epsm-metz-jury.fr
研究場所
-
-
Moselle
-
Jury、Moselle、フランス、57245
- 募集
- EPSM Metz-Jury
-
コンタクト:
- Claire GARIOT, Project Manager
- 電話番号:+33387561234
- メール:claire.gariot@epsm-metz-jury.fr
-
-
参加基準
適格基準
就学可能な年齢
- 大人
- 高齢者
健康ボランティアの受け入れ
サンプリング方法
調査対象母集団
説明
Inclusion Criteria:
- Adult patient (18 years or older)
- Receiving psychiatric care at EPSM Metz-Jury (inpatient unit, day hospital, community mental health center [CMP], or intensive home-based psychiatric care service [EPSIAD]/post-EPSIAD follow-up)
- Able to understand French
- Able to complete a self-report questionnaire independently or with assistance if needed
- Patients under legal protection measures (guardianship or curatorship) may participate with the agreement of their legal representative, when applicable
Exclusion Criteria:
- Major cognitive impairment
- Severe clinical condition preventing questionnaire completion or understanding of French
- Refusal to participate
- Prisoner or person deprived of liberty by judicial or administrative decision
研究計画
研究はどのように設計されていますか?
デザインの詳細
コホートと介入
グループ/コホート |
介入・治療 |
|---|---|
|
Adult psychiatric patients
Adult psychiatric patients receiving care at EPSM Metz-Jury (inpatient units, day hospital, community mental health centers [CMP], and intensive home-based psychiatric care services [EPSIAD]) who are able to complete self-report questionnaires in French.
|
Participants complete self-report questionnaires including the French version of the Recovery Assessment Scale (RAS-FR), the WHOQOL-BREF, and complementary questionnaires related to subjective recovery.
The study also includes the exploratory assessment of six additional existential items.
A subgroup of 50 participants will complete the RAS-FR again after one month to assess test-retest reliability.
No therapeutic intervention, modification of usual care, invasive procedure, or additional medical examination is involved.
|
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Recovery Assessment Scale - French Version (RAS-FR): Total Score, Internal Consistency, Factor Structure, and Test-Retest Reliability
時間枠:Baseline and 1 month
|
The Recovery Assessment Scale - French Version (RAS-FR) is a 41-item self-report questionnaire assessing subjective recovery in mental health.
Total scores range from 41 to 205, with higher scores indicating a higher level of subjective recovery.
Psychometric analyses will include internal consistency, dimensional structure, and test-retest reliability.
|
Baseline and 1 month
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Correlation between Recovery Assessment Scale - French Version (RAS-FR) and WHOQOL-BREF (World Health Organization Quality of Life - Brief Version) scores
時間枠:Baseline
|
Assessment of convergent validity through correlations between the Recovery Assessment Scale - French Version (RAS-FR) total score and WHOQOL-BREF domain scores in adult psychiatric patients, with particular attention to the psychological and social relationship domains.
The RAS-FR total score ranges from 41 to 205, with higher scores indicating a higher level of subjective recovery.
WHOQOL-BREF domain scores range from 0 to 100, with higher scores indicating better perceived quality of life.
Pearson or Spearman correlation coefficients will be calculated.
|
Baseline
|
|
Existential dimension of recovery (RAS-FR-EX) composite score
時間枠:Baseline
|
Exploratory assessment of the existential dimension of recovery using six additional items integrated into the French version of the Recovery Assessment Scale (RAS-FR-EX).
A composite score ranging from 6 to 30 will be calculated, with higher scores indicating a stronger endorsement of existential recovery processes.
|
Baseline
|
|
Development of a short-form Recovery Assessment Scale - French Version (RAS-FR-SF)
時間枠:Baseline
|
Exploratory item reduction analyses based on responses to the 41-item Recovery Assessment Scale - French Version (RAS-FR).
The objective is to identify a shorter version of the instrument while preserving its psychometric properties and conceptual coverage of subjective recovery.
|
Baseline
|
協力者と研究者
協力者
捜査官
- 主任研究者:Audrey WILLIG, Psychologist、Clinical Research Unit (URC), EPSM Metz-Jury
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (推定)
研究の完了 (推定)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
キーワード
その他の研究ID番号
- EPSM-VAL-RAS-FR
- 2026-A00601-50 (その他の識別子:ANSM)
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
IPD プランの説明
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。